Rossmore Private Capital’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $642K | Hold |
5,979
| – | – | 0.08% | 164 |
|
2025
Q1 | $603K | Buy |
5,979
+71
| +1% | +$7.16K | 0.07% | 160 |
|
2024
Q4 | $528K | Sell |
5,908
-45
| -0.8% | -$4.02K | 0.07% | 164 |
|
2024
Q3 | $499K | Hold |
5,953
| – | – | 0.06% | 169 |
|
2024
Q2 | $458K | Buy |
5,953
+72
| +1% | +$5.55K | 0.06% | 171 |
|
2024
Q1 | $403K | Buy |
5,881
+66
| +1% | +$4.52K | 0.05% | 187 |
|
2023
Q4 | $336K | Hold |
5,815
| – | – | 0.05% | 190 |
|
2023
Q3 | $307K | Sell |
5,815
-105
| -2% | -$5.54K | 0.05% | 189 |
|
2023
Q2 | $320K | Sell |
5,920
-63
| -1% | -$3.41K | 0.05% | 191 |
|
2023
Q1 | $299K | Hold |
5,983
| – | – | 0.05% | 192 |
|
2022
Q4 | $277K | Buy |
5,983
+168
| +3% | +$7.77K | 0.04% | 198 |
|
2022
Q3 | $225K | Hold |
5,815
| – | – | 0.04% | 205 |
|
2022
Q2 | $217K | Hold |
5,815
| – | – | 0.04% | 210 |
|
2022
Q1 | $258K | Hold |
5,815
| – | – | 0.04% | 203 |
|
2021
Q4 | $247K | Hold |
5,815
| – | – | 0.04% | 209 |
|
2021
Q3 | $252K | Hold |
5,815
| – | – | 0.04% | 201 |
|
2021
Q2 | $249K | Hold |
5,815
| – | – | 0.04% | 196 |
|
2021
Q1 | $225K | Hold |
5,815
| – | – | 0.04% | 200 |
|
2020
Q4 | $209K | Hold |
5,815
| – | – | 0.04% | 193 |
|
2020
Q3 | $222K | Hold |
5,815
| – | – | 0.05% | 180 |
|
2020
Q2 | $204K | Buy |
+5,815
| New | +$204K | 0.06% | 163 |
|
2020
Q1 | – | Sell |
-5,815
| Closed | -$263K | – | 150 |
|
2019
Q4 | $263K | Hold |
5,815
| – | – | 0.08% | 119 |
|
2019
Q3 | $237K | Hold |
5,815
| – | – | 0.08% | 123 |
|
2019
Q2 | $250K | Hold |
5,815
| – | – | 0.09% | 112 |
|
2019
Q1 | $223K | Buy |
+5,815
| New | +$223K | 0.08% | 120 |
|
2018
Q1 | – | Sell |
-5,260
| Closed | -$130K | – | 143 |
|
2017
Q4 | $130K | Buy |
+5,260
| New | +$130K | 0.13% | 114 |
|